HeMemics Biotechnologies Overview
- Founded
- 2007
- Status
- Private
- Employees
- 12
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $100K
- Investors
- 5
HeMemics Biotechnologies General Information
Description
Developer of a cell preservation platform designed to dehydrate biologics in dried or partially dried format for wider distribution and ease of use. The company's platform helps in preserving of mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature instead of frozen format, enabling medical practitioners to stabilize biologics in a dried or partially dried format for less damage to proteins or cells, ease of storage, transport and extended shelf-life.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
- 401 Professional Drive
- Suite 220
- Gaithersburg, MD 20879-3445
- United States
+1 (240) 000-0000
HeMemics Biotechnologies Timeline
HeMemics Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 14-Dec-2020 | $100K | 00.000 | Completed | Generating Revenue | |
| 7. Secondary Transaction - Private | 00.000 | Completed | Generating Revenue | |||
| 6. Seed Round | 11-Dec-2019 | 00.00 | 00.000 | 00.00 | Completed | Generating Revenue |
| 5. Angel (individual) | 25-May-2018 | 00000 | 00000 | Completed | Startup | |
| 4. Seed Round | 18-Dec-2017 | 00000 | 00000 | 00.000 | Completed | Startup |
| 3. Accelerator/Incubator | 01-Dec-2017 | 00000 | Completed | Startup | ||
| 2. Grant | 01-Jan-2012 | $185K | $107K | Completed | Startup | |
| 1. Accelerator/Incubator | 13-Aug-2007 | $107K | $107K | Completed | Startup |
HeMemics Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed 1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
HeMemics Biotechnologies Executive Team (8)
HeMemics Biotechnologies Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bruce Campbell | HeMemics Biotechnologies | Executive Officer & Board Member | 000 0000 |
| David Ho Ph.D | HeMemics Biotechnologies | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
| Hao Nguyen Ph.D | Self | Board Member | 000 0000 |
| Hao Nguyen | Self | Board Member | 000 0000 |
| James Hogarty | HeMemics Biotechnologies | Executive Officer & Board Member | 000 0000 |
HeMemics Biotechnologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHeMemics Biotechnologies Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| American Vietnamese Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Inova Strategic Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Maryland Industrial Partnerships | Other | Minority | 000 0000 | 000000 0 | |
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 |